MobiHealth News April 30, 2024
GenAI company for health plans Alaffia Health and oncology-focused clinical trial platform Klineo also secured funding.
New York City-based startup Trovo Health, which offers an AI-powered platform backed by a multidisciplinary clinical team that assists providers with complex tasks, announced its launch with $15 million in seed funding.
Oak HC/FT led the round. Cofounder and managing partner at Oak HC/FT, Andrew Adams, will join Trovo’s board of directors.
The company will use the funds to build its technology platform, clinical operations and leadership team.
“Adding new practice capabilities, both internal and patient facing, has always been a challenge for practices,” Niren Gandra, CEO and cofounder of Trovo Health, said in a statement. “By combining specialty-specific AI with expert clinical...
Today's Sponsors
Today's Sponsor